Correlation Between Enliven Therapeutics and Alvotech Warrant

Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Alvotech Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Alvotech Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enliven Therapeutics and Alvotech Warrant, you can compare the effects of market volatilities on Enliven Therapeutics and Alvotech Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Alvotech Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Alvotech Warrant.

Diversification Opportunities for Enliven Therapeutics and Alvotech Warrant

0.17

Correlation Coefficient

Enliven Therapeutics  Alvotech Warrant

Average diversification

The 3 months correlation between Enliven and Alvotech is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Alvotech Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech Warrant and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Alvotech Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech Warrant has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Alvotech Warrant go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Alvotech Warrant

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 96.92 times less return on investment than Alvotech Warrant. But when comparing it to its historical volatility, Enliven Therapeutics is 50.5 times less risky than Alvotech Warrant. It trades about 0.07 of its potential returns per unit of risk. Alvotech Warrant is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  273.00  in Alvotech Warrant on September 2, 2024 and sell it today you would lose (1.00) from holding Alvotech Warrant or give up 0.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	79.69%
Values	Daily Returns

Enliven Therapeutics  vs.  Alvotech Warrant

Enliven Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Alvotech Warrant

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech Warrant are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Alvotech Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enliven Therapeutics and Alvotech Warrant

The main advantage of trading using opposite Enliven Therapeutics and Alvotech Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Alvotech Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech Warrant will offset losses from the drop in Alvotech Warrant's long position.

The idea behind Enliven Therapeutics and Alvotech Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.